Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H16N2O |
Molecular Weight | 264.3217 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(C(=O)C2=CC=CN=C2)C3=C(N1)C=CC=C3
InChI
InChIKey=SOOXXPIIPHUERK-UHFFFAOYSA-N
InChI=1S/C17H16N2O/c1-11(2)16-15(13-7-3-4-8-14(13)19-16)17(20)12-6-5-9-18-10-12/h3-11,19H,1-2H3
Molecular Formula | C17H16N2O |
Molecular Weight | 264.3217 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/652049
Cats: forty minutes after intravenous administration of nictindole (2 mg/kg) the formation of platelet depostis was reduced by half. Three hours after i.v. administration of nictindole at a dose of 20 mg/kg the remaining anti-platelet activity was 18% for nictindole as compared to its antithrombotic action, which was recorded 40 min after their administration.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7126994
ATP and adenosine (10(-5) and 10(-4) M) caused a moderate contraction of the guinea-pig trachea under resting tone. This effect was antagonized by nictindole (10(-7) M).
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:54:30 GMT 2023
by
admin
on
Sat Dec 16 15:54:30 GMT 2023
|
Record UNII |
EDK3Z2X1IV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C002092
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
253-070-1
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
3259
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
C76805
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105174
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
SUB09251MIG
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
DTXSID30190004
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
65796
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
36504-64-0
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
100000084420
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY | |||
|
EDK3Z2X1IV
Created by
admin on Sat Dec 16 15:54:30 GMT 2023 , Edited by admin on Sat Dec 16 15:54:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |